Prestige Wealth Management Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88K | Sell |
19
-2
| -10% | -$303 | ﹤0.01% | 669 |
|
|
2025
Q1 | $3.16K | Sell |
21
-5
| -19% | -$753 | ﹤0.01% | 648 |
|
|
2024
Q4 | $4.8K | Hold |
26
| – | – | ﹤0.01% | 612 |
|
|
2024
Q3 | $5.12K | Buy |
26
+7
| +37% | +$1.38K | ﹤0.01% | 608 |
|
|
2024
Q2 | $3.93K | Hold |
19
| – | – | ﹤0.01% | 595 |
|
|
2024
Q1 | $5.15K | Hold |
19
| – | – | ﹤0.01% | 561 |
|
|
2023
Q4 | $4.49K | Hold |
19
| – | – | ﹤0.01% | 605 |
|
|
2023
Q3 | $3.72K | Hold |
19
| – | – | ﹤0.01% | 628 |
|
|
2023
Q2 | $4K | Hold |
19
| – | – | ﹤0.01% | 641 |
|
|
2023
Q1 | $3.84K | Hold |
19
| – | – | ﹤0.01% | 638 |
|
|
2022
Q4 | $4.14K | Hold |
19
| – | – | ﹤0.01% | 660 |
|
|
2022
Q3 | $4K | Sell |
19
-4
| -17% | -$842 | ﹤0.01% | 584 |
|
|
2022
Q2 | $5K | Buy |
23
+4
| +21% | +$870 | ﹤0.01% | 570 |
|
|
2022
Q1 | $5K | Hold |
19
| – | – | ﹤0.01% | 596 |
|
|
2021
Q4 | $7K | Hold |
19
| – | – | ﹤0.01% | 547 |
|
|
2021
Q3 | $8K | Hold |
19
| – | – | ﹤0.01% | 524 |
|
|
2021
Q2 | $7K | Hold |
19
| – | – | ﹤0.01% | 547 |
|
|
2021
Q1 | $6K | Hold |
19
| – | – | ﹤0.01% | 573 |
|
|
2020
Q4 | $5K | Hold |
19
| – | – | ﹤0.01% | 569 |
|
|
2020
Q3 | $4K | Hold |
19
| – | – | ﹤0.01% | 560 |
|
|
2020
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 594 |
|
|
2020
Q1 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 619 |
|
|
2019
Q1 | – | Sell |
-36
| Closed | -$4K | – | 634 |
|
|
2018
Q4 | $4K | Buy |
+36
| New | +$4K | ﹤0.01% | 629 |
|